BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1

Historical Holders from Q1 2014 to Q4 2020

Type / Class
Debt / NOTE 1.500%10/1
All holders as of 31 Dec 2020
Q4 2020
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-31
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1

Period Principal Value Change Price Investors
2020 Q4 0 $0 -$356,597,732 0
2020 Q3 357,830,003 $356,597,732 +$39,494,990 $1 31
2020 Q2 300,962,722 $403,720,012 +$10,712,324 $1.32 36
2020 Q1 308,997,716 $327,784,733 -$69,719,766 $1.06 43
2019 Q4 376,224,752 $408,859,034 +$23,268,637 $1.08 42
2019 Q3 355,672,715 $367,172,767 +$12,660,645 $1.03 42
2019 Q2 338,310,775 $380,676,320 +$29,874,539 $1.12 40
2019 Q1 311,697,275 $355,084,750 -$5,417,364 $1.14 36
2018 Q4 313,848,215 $349,728,786 +$2,820,486 $1.11 36
2018 Q3 309,548,014 $371,510,616 +$15,678,767 $1.2 39
2018 Q2 296,728,014 $350,176,017 -$5,722,720 $1.18 39
2018 Q1 301,833,012 $333,583,633 -$10,537,705 $1.1 38
2017 Q4 307,516,012 $365,262,609 +$35,523,840 $1.19 38
2017 Q3 277,558,000 $333,526,332 -$62,666,508 $1.2 38
2017 Q2 333,374,000 $396,972,968 -$7,996,093 $1.19 38
2017 Q1 340,001,000 $402,506,343 +$1,086,887 $1.18 40
2016 Q4 339,236,012 $399,582,215 +$28,890,823 $1.18 39
2016 Q3 313,097,012 $391,105,519 +$16,672,390 $1.25 41
2016 Q2 300,529,013 $347,575,209 +$10,238,101 $1.16 41
2016 Q1 291,502,000 $346,586,311 +$24,083,150 $1.19 42
2015 Q4 271,082,500 $363,534,359 -$19,897,266 $1.34 41
2015 Q3 285,934,000 $385,434,373 -$18,978,023 $1.34 40
2015 Q2 281,956,524 $449,251,630 -$19,201,721 $1.59 41
2015 Q1 299,622,500 $453,698,776 -$74,212,981 $1.51 42
2014 Q4 354,131,567 $433,715,692 -$23,247,766 $1.23 38
2014 Q3 375,079,000 $412,240,000 +$20,778,923 $1.1 40
2014 Q2 352,192,000 $372,338,000 +$32,130,318 $1.05 35
2014 Q1 324,994,000 $361,571,000 +$20,261,074 $1.11 37